Stock Report

All about this stock under one free report Last Updated: 22-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

SMS Pharma Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: SMSPHARMA | BSE: 532815

₹485.60

up-down-arrow ₹19.10 (4.09%)

As on 22-Sep-2026 11:34IST

Market cap

info icon

₹4,468 Cr

Revenue (TTM)

info icon

₹898 Cr

P/E Ratio

info icon

43.6

P/B Ratio

info icon

5.5

Div. Yield

info icon

0.1 %

Edit peer-selector-edit
SMS Pharma Wockhardt Rubicon Research Acutaas Chemicals Piramal Pharma
Market cap (₹ Cr)
 4,468 36,196 28,240 27,294 28,644
Revenue (₹ Cr)
 898 3,564 1,936 1,462 9,205
Net Profit (₹ Cr)
 89.48 414.00 288.22 387.35 -371.81
Net Margin (%)
 9.86 11.23 14.79 26.01 -3.93
RoE (%)
 13.52 8.38 29.77 25.18 -3.85
Price to Earnings
 43.63 88.50 97.98 70.67 --
Price-To-Book
 5.54 7.19 21.04 15.82 3.58

Income Statement (₹ Cr)

SMS Pharma Wockhardt Rubicon Research Acutaas Chemicals Piramal Pharma
Operating Revenue arrow
897.79 3,564.00 1,935.80 1,461.80 9,205.28
Total Income arrow
907.29 3,686.00 1,948.58 1,489.25 9,449.59
Total Expenditure arrow
724.93 2,792.00 1,485.56 919.25 8,195.15
EBITDA arrow
172.86 772.00 450.24 542.56 1,010.13
Depreciation arrow
40.16 226.00 50.83 37.68 857.51
EBIT arrow
132.70 546.00 399.41 504.88 152.62
Interest arrow
22.74 217.00 40.84 3.77 342.73
Other Income arrow
9.50 122.00 12.78 27.45 244.31
Exceptional Items arrow
0.00 12.00 0.00 0.00 -216.88
Profit before Tax arrow
119.47 463.00 371.35 528.56 -162.68
Provision for Tax arrow
29.99 49.00 83.14 141.21 209.13
Profit after Tax arrow
89.48 414.00 288.22 387.35 -371.81

Liabilities (₹ Cr)

SMS Pharma Wockhardt Rubicon Research Acutaas Chemicals Piramal Pharma
Shareholder's Funds arrow
785.81 4,940.00 1,288.82 1,653.56 8,162.62
Minority Interest arrow
0.00 -5.00 0.00 -1.13 0.00
Non-Current Liabilities arrow
223.65 1,712.00 202.03 42.40 5,044.14
Current Liabilities arrow
352.98 1,622.00 835.87 230.82 4,758.28
Total Liabilities arrow
1,387.80 8,578.00 2,326.71 1,983.96 17,723.32

Assets (₹ Cr)

SMS Pharma Wockhardt Rubicon Research Acutaas Chemicals Piramal Pharma
Non-Current Assets arrow
681.94 5,343.00 519.60 1,026.85 10,211.52
Current Assets arrow
638.01 2,606.00 1,681.81 881.27 7,191.66
Total Assets arrow
1,387.80 8,578.00 2,326.71 1,983.96 17,723.32
Total Debt* arrow
365.05 2,125.00 259.37 26.49 5,495.48
Net Current Assets arrow
285.04 984.00 845.94 650.46 2,433.38
Contingent Liabilities arrow
56.89 768.26 19.09 17.25 95.72

Cashflow (₹ Cr)

SMS Pharma Wockhardt Rubicon Research Acutaas Chemicals Piramal Pharma
Cash From Operating Activities arrow
59.22 390.00 205.05 292.17 1,652.60
Cash Flow from Investing Activities arrow
-130.78 -241.00 -409.72 -265.94 -826.03
Cash from Financing Activities arrow
76.03 -54.00 283.07 4.10 -38.98
Net Cash Inflow / Outflow arrow
4.48 95.00 78.39 30.33 787.59

Ratios

Profitability Ratios

 SMS Pharma Wockhardt Rubicon Research Acutaas Chemicals Piramal Pharma
ROCE (%) arrow
13.32 6.79 29.22 32.42 1.24
ROE (%) arrow
13.52 8.38 29.77 25.18 -3.85
ROA (%) arrow
7.12 4.94 24.77 21.93 -2.21
EBIT Margin (%) arrow
14.78 15.32 20.63 34.54 1.66
Net Margin (%) arrow
9.86 11.23 14.79 26.01 -3.93
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 SMS Pharma Wockhardt Rubicon Research Acutaas Chemicals Piramal Pharma
Revenue Growth (%) arrow
10.25 18.37 46.65 40.90 0.78
EBIT Growth (%) arrow
21.59 252.26 62.13 124.50 -70.53
Net Profit Growth (%) arrow
28.31 377.85 89.49 104.15 -1,383.43
EPS Growth (%) arrow
29.81 1,001.33 78.60 42.32 -484.84
Book Value Growth (%) arrow
25.98 13.47 144.31 26.03 0.33

Valuation Ratios

 SMS Pharma Wockhardt Rubicon Research Acutaas Chemicals Piramal Pharma
Price / Earnings arrow
42.66 89.21 97.91 72.55 -91.33
Price / Book Value arrow
5.42 7.06 21.35 16.24 3.57
Dividend Yield (%) arrow
0.09 0.00 0.09 0.07 0.00
EV/EBITDA arrow
27.12 47.94 63.46 51.28 32.39
Market Cap (₹ Cr) arrow
3,509.17 19,071.62 12,753.19 20,944.75 18,108.89

Solvency Ratios

 SMS Pharma Wockhardt Rubicon Research Acutaas Chemicals Piramal Pharma
Debt to Equity arrow
0.22 0.31 0.11 0.02 0.53
Short term debt to equity ratio arrow
0.19 0.09 0.05 0.02 0.09
Current Ratio arrow
1.81 1.61 2.01 3.82 1.51
Quick Ratio arrow
0.81 1.06 1.14 2.82 0.87
Interest Coverage arrow
6.25 3.13 10.09 141.16 0.53

Operating Efficiency Ratios

 SMS Pharma Wockhardt Rubicon Research Acutaas Chemicals Piramal Pharma
Debtors to sales (%) arrow
24.04 16.50 26.28 24.80 23.44
Asset Turnover arrow
0.71 0.43 1.66 0.83 0.55
Receivable days arrow
76.30 58.75 40.13 88.98 78.20
Inventory Days arrow
115.77 75.82 60.29 56.04 93.30
Payable days arrow
86.69 186.21 232.47 99.95 226.14
Cash Conversion Cycle arrow
105.37 -51.64 -132.04 45.07 -54.64
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...